- ►asnjournals.org GA Block, PS Klassen, JM Lazarus, N … - Journal of the American Society of Nephrology, 2004 - Am Soc Nephrol ABSTRACT. Mortality rates in ESRD are unacceptably high. Disorders of mineral
metabolism (hyperphosphatemia, hypercalcemia, and secondary hyperparathyroidism)
are potentially modifiable. For determining associations among disorders of ... Cited by 704 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org J Hsia, G Heiss, H Ren, M Allison, NC Dolan … - Circulation, 2007 - Am Heart Assoc From the Department of Medicine, George Washington University, Washington, DC
(JH); Department of Epidemiology, University of North Carolina School of Public
Health, Chapel Hill (GH); Fred Hutchinson Cancer Research Center, Seattle, ... Cited by 93 - Related articles - All 7 versions
- ►oxfordjournals.org D Hamerman - Qjm, 2005 - Oxford Univ Press Osteoporosis and atherosclerosis are both widely prevalent in an ageing
population, and induce serious morbidities and death. There is growing evidence
that in addition to their relationship to ageing, osteoporosis and ... Cited by 61 - Related articles - BL Direct - All 9 versions
JA Cauley, RL Fullman, KL Stone, JM Zmuda, … - Osteoporosis international, 2005 - Springer Factors associated with the lumbar spine and proximal femur bone ... Jane A.
Cauley Æ Robin L. Fullman Æ Katie L. Stone Joseph M. Zmuda Æ Douglas C. Bauer
Elizabeth Barrett-Connor Æ Kristine Ensrud Edith MC Lau Æ Eric S. Orwoll ... Cited by 59 - Related articles - BL Direct - All 4 versions
C Hatzigeorgiou, JL Jackson - Osteoporosis International, 2005 - Springer Abstract Studies determining the association between
hydroxymethylglutaryl-coenzyme A (HMG-CoA) reduc- tase inhibitors (statins) and
bone metabolism are mixed. We conducted a systematic review to assess the ... Cited by 40 - Related articles - BL Direct - All 3 versions
SA Brown, JL Sharpless - Clinical Diabetes, 2004 - Am Diabetes Assoc Care of patients with diabetes should include an assessment of bone health. It
is now clear that patients with type 1 diabetes have lower bone mineral density
(BMD) and higher risk of fractures. Evidence is accumulating that patients ... Cited by 32 - Related articles - BL Direct - All 2 versions
KI Paraskevas, AA Tzovaras, DD Briana, DP … - Current Pharmaceutical Design, 2007 - ingentaconnect.com 1 Honorary Clinical Research Fellow, Dept. of Clinical Biochemistry and Academic
Dept. of Surgery, Royal Free Hospital, London, UK; 2 3 rd Department of Internal
Medicine, “Elpis” General Hospital, Athens, Greece; Cited by 32 - Related articles - BL Direct - All 2 versions
RJ Glynn, S Schneeweiss, PS Wang, R Levin, … - Journal of Clinical Epidemiology, 2006 - Elsevier In age- and sex-adjusted analyses, users of lipid-lowering drugs had a 43%
reduced death rate relative to nonusers among hospitalized enrollees and a 56%
reduction in the nonhospitalized sample. Available markers of frailty and ... Cited by 30 - Related articles - All 9 versions
SB Jadhav, GK Jain - Journal of Pharmacy and Pharmacology, 2006 - ingentaconnect.com Osteoporosis is the most common bone disease, affecting millions of people
worldwide and leading to significant morbidity and high expenditure. Most of the
current therapies available for its treat- ment are limited to the ... Cited by 28 - Related articles - BL Direct - All 4 versions
M Alegret, JS Silvestre - Methods Find Exp Clin Pharmacol, 2006 - journals.prous.com Statins, the most widely prescribed cholesterol-lowering drugs, are considered
to be first-line therapeutics for the prevention of coronary heart disease and
atherosclerosis. Statins act by inhibiting the enzyme ... Cited by 22 - Related articles - All 8 versions
